Dexcom, Inc. 8-K Filing: Key Updates on September 14, 2025
Based on the provided XML section of the financial report, here are the key pieces of information extracted:
- Filing Type and Date:
- Form Type: 8-K
- Filing Date: September 14, 2025
- Company Information:
- Company Name: Dexcom, Inc.
- State of Incorporation: Delaware (DE)
- CIK (Central Index Key): 0001093557
- SEC File Number: 000-51222
- IRS Employer Identification Number (EIN): 33-0857544
- Address:
- Location: 6340 Sequence Drive, San Diego, CA 92121
- Phone Number: 858-200-0200
- Securities Information:
- Type of Security: Common Stock
- Par Value: $0.001 per share
- Ticker Symbol: DXCM
- Exchange: NASDAQ
- Context Information:
- Context ID: c-1
- Period Start and End Date: September 14, 2025 (indicates this report is for a single day)
Insights:
- The 8-K filing indicates that Dexcom, Inc. has reported significant or material events that require immediate disclosure. Since this is a one-day report, it could pertain to a specific event or announcement that occurred on this date.
- The inclusion of the company’s address and contact information suggests that they are maintaining transparency and accessibility for stakeholders.
- The mention of common stock with a low par value might indicate that the company is focused on growth and investment opportunities, typical within the biotech and medical device sectors.
This information is crucial for investors, analysts, and stakeholders who are monitoring the company's developments and financial situation.